News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. CSX (CSX) has drawn investor attention after recent trading data showed a modest move over the past week, alongside mixed shorter term returns and …
Sharemaestro market context Trend signal active 52 weeks +47.1%Teddy Ray Price, a director at Red River Bancshares Inc. (NASDAQ: RRBI), recently purchased $111,798 worth of the company's common stock, transacting at prices between $99.89 and $101.31 per share. These purchases, made on August 10, 2026, come as RRBI trades near its 52-week …
Monte Rosa Therapeutics (GLUE) reported widening net losses for Q2 and the first half of 2026, marking a significant shift from prior-year profitability. This financial downturn, with a net loss of US$87.9 million for the six-month period, deepens the investment risk, highlighting the company's …
Andrew Rees, Chief Executive Officer, sold 30,000 shares of Crocs, Inc. (NASDAQ:CROX) at a weighted average price of $138.49 per share. SEC Form 4 filing Transaction summary Metric Value Transaction value ~$4.2 million Shares sold (indirectly held) 30,000 Post-transaction shares (directly held) ~570,000 Post-transaction …
Sharemaestro market context Trend signal active 52 weeks +47.9% · Next-week setup negative 37.0%The State of Wyoming acquired a new position of 11,780 shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) valued at approximately $1.35 million during the second quarter. This comes as Kymera reported stronger-than-expected quarterly results with a significant revenue increase, although insiders sold a substantial amount …
PACS Group reported strong Q2 2026 results and raised its full-year 2026 revenue guidance to US$5.75 billion to US$5.85 billion. This update supports near-term growth but highlights the ongoing dependence on Medicaid rate structures and quality incentives, which could impact margins. The article encourages …
Oppenheimer Asset Management Inc. has acquired a new position of 14,518 shares in CSW Industrials, Inc. (NYSE:CSW), valued at approximately $4.04 million. CSW Industrials recently reported strong quarterly earnings, beating analyst estimates with an EPS of $3.84 and a 33% year-over-year revenue increase. The …
GXO Logistics (GXO) has returned to profitability in the first half of 2026 with sales of US$3,441 million for the quarter. While the stock has seen declining long-term shareholder returns, its share price has recently shown a modest 3.05% return over 90 days. The …
GSA Capital Partners LLP recently acquired a new position of 23,257 shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) during the second quarter, valued at approximately $2.022 million. Other institutional investors have also adjusted their holdings in CORT, with 93.61% of the stock owned by hedge …
Focus Partners Advisor Solutions LLC has invested $6.70 million in General Dynamics Corporation by acquiring 18,907 shares. This comes amidst other institutional investors modifying their holdings and various analysts issuing reports with target price adjustments and ratings for General Dynamics, which recently reported strong …
Bank of America Corp DE significantly increased its stake in PennyMac Financial Services (NYSE:PFSI) by 173.9% in the first quarter, acquiring an additional 240,902 shares. This brings their total holding to 379,429 shares, valued at approximately $33.2 million. Despite PennyMac missing its Q1 EPS …
ABN AMRO Bank N.V. recently acquired a new position in Quest Diagnostics Incorporated, purchasing 101,667 shares valued at approximately $21.52 million during the second quarter. This investment makes ABN AMRO Bank N.V. an approximate 0.09% owner of the medical research company. Other institutional investors …
TransMedics Group, Inc. (NASDAQ:TMDX) has received a consensus "Hold" rating from brokerages, with six analysts recommending "buy," six "hold," and one "sell." The average 12-month price target for the stock is $124.18. The company recently reported quarterly revenue of $189.95 million, exceeding estimates, but …
Wall Street Zen has upgraded Astronics (NASDAQ:ATRO) to a "strong-buy" rating, while the broader analyst consensus remains "Buy" with an average price target of $74.17. The aerospace company recently reported strong quarterly results, with EPS of $0.70, beating estimates, and revenue of $259.96 million, …
Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …
Wall Street Zen upgraded Cytokinetics (NASDAQ:CYTK) from "Sell" to "Hold" on Sunday, despite the broader analyst consensus remaining a "Moderate Buy." The company exceeded quarterly expectations with an adjusted loss of $1.50 per share and revenue of $28.62 million. While company insiders sold shares, …
Wall Street Zen has upgraded Atara Biotherapeutics (NASDAQ:ATRA) from "Sell" to "Hold," reflecting an average "Hold" consensus among analysts with an average price target of $9.50. Despite the upgrade, ATRA shares opened down 4.9% at $8.09, with the company reporting a quarterly loss of …
Wall Street Zen has upgraded Home BancShares (NYSE:HOMB) from a "sell" to a "hold" rating, aligning with the overall analyst sentiment of "Hold." The company recently reported strong quarterly earnings, exceeding estimates with an EPS of $0.64 and revenue of $295.1 million, an 8.9% …
Search by ticker symbol or company name and select a result to open its chart.